Noveris Health Sciences Inc. NVRS
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 569.30K | 1.46M | 7.10K | 33.80K | 200.00 |
| Total Receivables | 19.30K | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 106.90K | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 695.50K | 1.46M | 7.10K | 33.80K | 200.00 |
|
|
|||||
| Total Current Assets | 695.50K | 1.46M | 7.10K | 33.80K | 200.00 |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 14.40K | -- | -- | -- |
| Total Assets | 695.50K | 1.47M | 7.10K | 33.80K | 200.00 |
|
|
|||||
| Total Accounts Payable | 1.16M | 1.40M | 3.18M | 1.78M | 1.69M |
| Total Accrued Expenses | 321.10K | 378.70K | 404.80K | 4.15M | 4.39M |
| Short-term Debt | 99.90K | 97.10K | 6.98M | 91.40K | 89.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 161.60K | 207.60K | 6.79M | 4.89M | 5.06M |
| Total Finance Division Other Current Liabilities | 527.70K | 1.01M | 263.40K | -- | -- |
| Total Other Current Liabilities | 527.70K | 1.01M | 263.40K | -- | -- |
| Total Current Liabilities | 2.27M | 3.09M | 8.94M | 10.92M | 11.23M |
|
|
|||||
| Total Current Liabilities | 2.27M | 3.09M | 8.94M | 10.92M | 11.23M |
| Long-Term Debt | -- | -- | 103.20K | -- | -- |
| Short-term Debt | 99.90K | 97.10K | 6.98M | 91.40K | 89.00K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 59.40K | -- | -- |
| Total Liabilities | 2.27M | 3.09M | 9.10M | 10.92M | 11.23M |
|
|
|||||
| Common Stock & APIC | 108.53M | 110.76M | 103.85M | 102.71M | 104.89M |
| Retained Earnings | -110.10M | -112.38M | -112.94M | -113.79M | -116.33M |
| Treasury Stock & Other | -- | -- | -- | 205.20K | 209.50K |
| Total Common Equity | -1.57M | -1.62M | -9.10M | -10.88M | -11.23M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.57M | -1.62M | -9.10M | -10.88M | -11.23M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.57M | -1.62M | -9.10M | -10.88M | -11.23M |
|
|
|||||